![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Amryt Pharma Plc | LSE:AMYT | London | Ordinary Share | GB00BKLTQ412 | ORD 6P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 143.00 | 151.00 | 170.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/3/2020 13:21 | Is it terminal, ab321? :-) | ![]() papillon | |
09/3/2020 08:32 | Amryt has caught Corona | ![]() alphabravo321 | |
02/3/2020 08:41 | I think we are due a trading update shortly... | ![]() alphabravo321 | |
01/3/2020 20:22 | Bloody hell, West Ham won and Liverpool lost! Wonders never cease! Could be bad news for some of those dependent on repeat prescriptions for medical conditions. | ![]() papillon | |
28/2/2020 16:53 | Every cloud has a silver lining. COVID-19 could yet save West Ham from relegation and scupper Liverpool's league title prospects! Unless this Corona virus panic and the consequent containment measures prove to be short term then the 2020 Euro's and Olympics must also be at risk. bazworth 28 Feb '20 - 15:13 - 5263 of 5264 (Filtered) albundi1 28 Feb '20 - 16:10 - 5264 of 5264 (Filtered) | ![]() papillon | |
28/2/2020 15:13 | Brilliant!! | ![]() bazworth | |
28/2/2020 12:41 | You are such a fountain of knowledge Papillon. The market is in decline after dropping 1000 points in a week and your prognosis amryt may fall is proved right. Gosh you are so clever and insightful. | ![]() positivitynicholas | |
28/2/2020 10:42 | paps All you need to do is look at the wider market! | ![]() bazworth | |
28/2/2020 10:18 | Looking like my short term share price prognosis will be proved correct as the share price has just started to fall. | ![]() papillon | |
27/2/2020 15:12 | I hope I'm wrong because I hold 4,750 AMYT shares, but I can see this falling back down to 110p, or even lower, if investors continue to panic over the effects of this COVID-19 virus on the global economy. One thing's for certain and that is AMYT wont be listing on NASDAQ anytime soon if the panic continues because NASDAQ is currently in freefall. Not a good time to list on it!! | ![]() papillon | |
26/2/2020 13:50 | AMYT share price is suffering from COVID-19 syndrome! :-). Corona virus panic selling has spread to AMYT. :-) | ![]() papillon | |
21/2/2020 10:27 | Many thanks, bazworth. The dodgy post had obviously been deleted before I saw sidam's post. | ![]() papillon | |
21/2/2020 10:16 | papillion there was a dodgy post on dozens of bb's suggesting we all click a weblink. It was on the other bb's that I look at too but would appear to have been deleted from all. I would guess by advfn. Cheers | ![]() bazworth | |
21/2/2020 07:44 | Beware looks like at least spam and could be worse. | ![]() sidam | |
20/2/2020 20:50 | Posted on the lse bb Bronxville Posts: 1,528 Price: 128.50 No Opinion Therapy to make waves this year Today 12:29 >>>>> Possible bullish Inverse Head & Shoulders (IH&S) forming on AMYT chart. Will it form? Will it be soon? Depends on the news, but a Nasdaq listing would do it. Target share price > 150p. free stock charts from uk.advfn.com | ![]() papillon | |
19/2/2020 15:02 | Brokers were looking for sales to be US$21m in 2019 but in September the company concluded a transformational acquisition when it bought two commercial orphan drugs and revenues on a proforma basis are closer to US$150m, with the expectation building that they could climb to US$165-US$168m in the current year. With the US being the bulk of its sales and many of its shareholders there, the company is expected to seek a NASDAQ-listing later this year. | ![]() nw99 | |
19/2/2020 14:34 | Looks a great buy here | ![]() nw99 | |
19/2/2020 14:19 | "Amryt, a global, commercial-stage biopharmaceutical company dedicated to commercializing and developing novel therapeutics to treat patients suffering from serious and life-threatening rare diseases, announces today that it has confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission ("SEC") relating to the proposed listing of American Depositary Shares ("ADSs") representing Amryt ordinary shares on the Nasdaq stock market ("Nasdaq")." finally !! | ![]() delta0091 | |
19/2/2020 13:27 | we may well be off to the races!! | ![]() bazworth |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions